Antimicrobial susceptibility, pneumococcal surface protein A (PspA) serotyping, and pulsed-field gel electrophoresis (PFGE) were used to evaluate clonal relatedness among 66 invasive isolates of Streptococcus pneumoniae serotype 6B collected during 1982-1996 from patients in Alaska. Thirty-seven (56%) of the isolates had penicillin minimal inhibitory concentration values у0.125 mg/mL and were resistant to at least 1 other antibiotic. Fourteen PspA serotypes were observed; PspA 16 was the most common (35%). Forty-five (68%) of the 66 isolates shared common and highly related PFGE patterns using 3 enzymes. Twenty-six (58%) of the isolates with common PFGE patterns were from Native Alaskan children р2 years of age residing in 1 region of Alaska. The PFGE patterns of Alaskan serotype 6B were distinct from those of the South African 6B-8 and Spanish 6B-2 multidrug-resistant clones, suggesting that the Alaskan 6B isolates were distinct from these other pneumococcal 6B clones but genetically related to them.
African 6B-8, Spanish 6B-2) share a recent common ancestor or emerged independently.
In Alaska, high rates of invasive pneumococcal disease have been reported in Native Alaskan children р2 years of age, where in 1 region, rates exceed 1000 cases/100,000 persons per year [13] . Statewide, the average annual incidence rate for invasive pneumococcal disease, age-adjusted to the 1990 census, was 77 cases/100,000 persons for Native Alaskans and 16/ 100,000 persons for nonnatives of all ages. For both ethnic groups, the highest rates occurred in children !2 years of age: 308/100,000 in Native Alaskan and 98/100,000 in non-Native Alaskan children. In addition, the number of pneumococcal isolates causing invasive disease, particularly in children, with both reduced susceptibility to penicillin (MIC у0.125 mg/mL) and full resistance to other antibiotics, has been steadily increasing since 1986 [14] . This has been particularly evident in the Yukon-Kuskokwim Delta (YKD) health service unit region, where the proportion of penicillin-nonsusceptible pneumococcal isolates has reached 50%. The YKD also has the highest proportion of isolates resistant to у1 antibiotics; of these multidrug-resistant isolates, 80% have been identified as serotype 6B [14] . The large representation in Alaska of a single pneumococcal serotype that is associated with a multidrugresistant phenotype supports previous findings suggesting that the increase in prevalence and incidence of isolates of these bacteria may be due primarily to the emergence of a unique clone.
In this study, 3 different epidemiologic typing systems-antibiogram, pneumococcal surface protein A (PspA) serotyping, and pulsed-field gel electrophoresis (PFGE)-were [7, 15] .
Materials and Methods
Study population. Surveillance for invasive pneumococcal disease was initiated in the YKD region of Alaska in 1982 and extended to include all residents of the state in 1986. The ethnic and demographic characteristics of the population under surveillance have been described elsewhere [13] . Participating laboratories were requested to send any pneumococcal isolates recovered from a normally sterile site (blood or cerebrospinal, pleural, peritoneal, or joint fluid) to the Arctic Investigations Program (AIP). On the basis of the review of culture records and patient charts from the participating laboratories, we determined that 85% of pneumococcal isolates causing invasive disease in Alaska were captured by this surveillance system [14] .
Bacterial isolates. A total of 66 isolates of invasive S. pneumoniae serotype 6B were characterized from a collection of 142 serotype 6B isolates submitted to AIP as part of the surveillance program. The first 26 isolates characterized were selected from the collection of serotype 6B isolates on the basis of their nonsusceptibility to penicillin. The remaining 40 isolates included both penicillin-susceptible and -nonsusceptible isolates and were chosen at random. These 66 isolates were recovered from patients ranging in age from !1 year to 93 years residing in different geographic regions across the state and were collected between January 1982 and December 1996. Pneumococci were identified by colony morphology, susceptibility to ethylhydroxycypreine hydrochloride (Optochin; Difco Laboratories, Detroit), and bile solubility. All isolates were typed with serotype-specific antisera by the Quelling reaction [16] at the Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta.
Susceptibility testing. Susceptibility testing was performed by using the standard agar dilution method as described by the National Committee for Clinical Laboratory Standards (NCCLS) for penicillin, erythromycin, trimethoprim-sulfamethoxazole (TMP-SMX), and tetracycline [17] . The MIC was determined to be the lowest concentration of antibiotic that inhibited growth. Susceptibility patterns to penicillin were classified as intermediate (0.125-1.0 mg/mL) and resistant (у2.0 mg/mL) MIC as recommended by NCCLS [17] . TMP-SMX intermediate and resistant isolates were defined as having MICs of 1/19-2/38 mg/mL and у4/ 76 mg/mL, respectively. Resistance to tetracycline was defined as an MIC of у8 mg/mL; erythromycin-intermediate and resistant isolates were defined as having an MIC of 0.5 and у1 mg/mL, respectively, by using NCCLS breakpoints [17] . Multidrug resistance was defined as having intermediate or full resistance to 2 different classes of antibiotics [18] .
PspA serotyping. PspA serotyping was performed according to Crain et al. [19] . Serotypes were assigned to each isolate on the basis of the pattern of reactivity to the panel of monoclonal antibodies to PspA tested.
DNA preparation and restriction enzyme digestion. Bacteria were grown for 18-22 h at 37ЊC in 5% CO 2 on Brucella agar plates (Difco) supplemented with 5% sheep blood. Bacterial DNA was prepared in agarose blocks [20] . Briefly, bacterial cells were resuspended in 2 mL Muellar Hinton broth (Difco) to an optical density at 560 nm, adjusted to read between 0.4 and 0.6. The cells were centrifuged at 8160 g for 2 min, then resuspended in 500 mL of low-melting point agarose (Bio-Rad Laboratories, Richmond, CA) prepared in 0.5ϫ Tris/boric acid/EDTA buffer (TBE; 45 mM Tris, 45 mM boric acid, 1 mM disodium EDTA [pH 8.0]) held at 50ЊC. Each bacterial suspension was poured into Plexiglas molds (BioRad) and, once solidified, the agarose blocks were incubated in Tris-EDTA buffer (0.01 M Tris, 0.001 M EDTA, [pH 8.1]) supplemented with 1 mg/mL proteinase K and 1% sodium dodecyl sulfate at 50ЊC. Gel plugs were cut from the blocks and digested with 35 U of enzyme overnight in 150 mL of sterile, distilled water with 22 mL of the appropriate 10ϫ restriction buffer [20] . Three enzymes with rare recognition sites were used: ApaI (Promega, Madison, WI) recognized 5 -GGGCCC-3 , SmaI (Promega) recognized 5 -CCCGGG-3 , and SacII (Promega) recognized 5 -CCGCGG-3 .
PFGE. The digested DNA plugs were placed in wells of a 1% agarose gel (SeaKem; FMA, Rockland, ME) prepared in 0.5ϫ TBE (pH 8.0) and electrophoresed in a contour-clamped homogeneous electric field apparatus (CHEF DRIII; Bio-Rad) with initial to final switch times ranging from 1 to 15 s at 175 volts for 20 h with SmaI-and SacII-digested DNA plugs and 22 h with ApaI-digested DNA plugs [20] . Gels were stained with ethidium bromide solution (1 mg/mL) for 1 h, destained in distilled water for 4 h, and photographed under ultraviolet transillumination.
Analysis of PFGE profiles. PFGE profiles were analyzed by visual inspection of photographs of ethidium bromide-stained gels [20] . ApaI digests yielded patterns of 10-15 fragments of 48.5-242.5 kb. SmaI digests yielded patterns of 8-10 fragments of 48.5-242.5 kb. SacII digests yielded patterns of 8-12 fragments of 48.5-242.5 kb. Isolates were assigned a major pattern designation by using the first or last letter of the enzyme and a number representing a distinct pattern identified after digestion with that enzyme (ApaI-A1, SmaI-S1 or SacII-C1). When band differences were consistent with a single genetic event (1-to 3-band differences), isolates were assigned to the same subtype (e.g., A1 1 , S1 1 , C1 1 ), as described elsewhere [20] [21] [22] . Isolates differing by 13 bands were considered unrelated [23] . Isolates were considered genetically related if they showed 0-to 3-band differences for 2 or 3 enzymes, which is a more stringent criterion than that used by others [8, 24, 25] . For purposes of simplifying the data, a combined PFGE pattern number was assigned to each isolate.
Results
Between 1 January 1982 and 31 December 1996, a total of 1490 invasive pneumococcal isolates were received from 23 participating laboratories. These 1490 isolates were of 39 different serotypes, 142 (9.5%) of which were serotype 6B. The sample of 66 serotype 6B isolates characterized in this study represented 46% of the total number of serotype 6B isolates recovered over this time. Among the 66 isolates characterized, there were no statistically significant differences between the ethnicity (P = ) or sex ( ) of patients from whom the isolates were .672 P = .842 recovered, when compared with patients whose isolates were not characterized (table 1) . However, although the mean ages of patients in both groups were similar, the isolates that were characterized were more likely to be from patients 12 years of age than from those р2 years old (
). There were some P = .013 differences in the representativeness of the patients with isolates that were characterized by geographic region. Of the 6B isolates from patients from the YKD, 74% (31/42) were characterized versus 0% (0/11) from the Southeast and 39% (35/89) from all other regions (figure 1) There was no significant difference in the distribution of isolates over time (1982-1985, 1986-1990, 1991-1996) between those sampled and those isolates not sampled ( ; data not shown). P = .129 Antimicrobial susceptibility. All 66 invasive isolates were analyzed and assigned to 1 of 5 antibiotic profiles on the basis of their susceptibility to penicillin, erythromycin, tetracycline, and TMP-SMX (table 2) . Fifty-six percent (37/66) were identified with either intermediate or full resistance to penicillin (MIC у0.125 mg/mL; profiles B-D). Of these penicillin-nonsusceptible isolates, 84% (31/37) were from Native Alaskan patients; the majority ( ) were from children !2 years of age n = 23 residing in the YKD region. Twenty-nine (44%) of the 66 isolates were multidrug resistant (profiles C and D); of these, 83% Analysis of pneumococcal DNA by PFGE. Among the 66 isolates, 7 different PFGE patterns were detected after restriction with SmaI (S1, S2, S22-S25). Each SmaI pattern differed from all other SmaI patterns by 13 bands. Pattern S1, which was classified into 6 subtypes, accounted for 70% (46/66) of the isolates. Nine different PFGE patterns were detected after restriction with SacII (C1-C9). SacI pattern C1, which was divided into 5 subtypes, accounted for 71% (47/66) of the isolates. Restriction with ApaI resulted in 12 different PFGE patterns (A1, A3, A27-A36). Pattern A1 was subdivided into different 4 patterns and accounted for 53% (35/66) of the isolates.
A total of 21 different PFGE types were identified after combining the results of 3 individual enzyme-restriction patterns. Seventeen isolates were indistinguishable after restriction with all 3 enzymes. Fourteen isolates showed highly related PFGE patterns and were designated as subtypes of pattern S1C1A1 by using 3 enzymes. An additional 16 isolates showed highly related PFGE patterns after restriction with 2 of the 3 enzymes. These 47 isolates were combined into PFGE pattern 1 and represented 71% (47/66) of the total isolates characterized (table 2); combined PFGE patterns 2, 3, and 4 represented 12% (8/ 66), 6% (4/66), and 11% (7/66), respectively.
Comparison of genetically related and genetically unrelated serotype 6B isolates from Alaska. Among the 31 invasive isolates with indistinguishable or highly related ApaI, SmaI, and SacII PFGE patterns after restriction with 3 enzymes, 24 (77%) were penicillin nonsusceptible (B-D) and 21 (68%) were multidrug-resistant (C, D) (table 3). Five different PspA serotypes were identified within this group of 31 isolates; the 2 most common, PspA types 16 and 9, accounted for 71% of these isolates. Among the 16 invasive isolates with indistinguishable or highly related PFGE patterns after restriction with 2 of the 3 enzymes, only 4 (25%) were penicillin nonsusceptible (B, C), while the majority (69%; 11/16) were susceptible (A) to all 4 antibiotics tested (table 3) . When we combined isolates indistinguishable or highly related after restriction with 2 and 3 enzymes, we found that 70% (33/47) were recovered from patients !2 years of age, 66% (31/47) were recovered from Native Alaskan patients, and 55% (26/47) of these patients resided in the YKD region.
Among the remaining 19 invasive isolates analyzed, 17 different PFGE patterns were observed. The antibiograms of these (13) 8 (26) NOTE. PspA, pneumococcal surface protein A; ND, not determined, which includes the 6 isolates unavailable for PspA serotyping.
a Indistinguishable or related after restriction with 3 and 2 enzymes, respec- isolates were variable, ranging from susceptible (37%) to multidrug-resistant (33% Figure 2 shows the SmaIand SacII-fragmentation patterns of the previously described penicillin-resistant 6B clones recovered from patients in South Africa (lanes 1 and 5), Spain (lanes 2 and 6) [7, 15] , and a representative of the Alaska serotype 6B genetically related isolates (PFGE pattern S1C1A1, lanes 3 and 7). The serotype 6B isolates from Spain and South Africa showed PFGE chromosomal patterns that differed from the pattern of the Alaska 6B isolate.
Discussion
In this study we used 3 typing systems-antimicrobial susceptibility, PspA serotyping, and PFGE-to evaluate clonal relatedness among 66 invasive pneumococcal serotype 6B isolates recovered from patients residing in different regions of Alaska over a 14-year period. While antibiogram and PspA serotyping were useful for preliminary identification of genetically related pneumococci, PFGE using 3 enzymes could further group these isolates. When we analyzed the PFGE patterns of the 66 penicillin-susceptible, nonsusceptible, and multidrug-resistant serotype 6B isolates from Alaska, 47 (71%) were found to share variants of a common PFGE pattern after being cut with 2 or 3 restriction enzymes. Of these 47 isolates, 31 (66%) showed indistinguishable or highly related PFGE patterns after being cut with 3 enzymes. Fourteen carriage isolates of serotype 6B collected from the YKD region in 1992 were also analyzed in this study, and the majority (64%; 9/14) were genetically very similar to this group of 47 invasive isolates. Perhaps the most interesting finding in this study was the appearance of multidrug-resistant traits among these genetically related serotype 6B pneumococcal isolates within a single remote region, the Yukon-Kuskokwim Delta of Alaska. The first serotype 6B isolates to show intermediate resistance to penicillin were recovered in 1982. Erythromycin resistance was detected in an isolate in 1987, followed 2 years later by TMP-SMZ resistance. These serotype 6B isolates have been recovered primarily from Native Alaskan patients !2 years of age residing in the YKD and have yet to achieve levels of penicillin resistance у2 mg/mL.
In 1990, a single isolate with the same antibiogram and PFGE pattern as the genetically related serotype 6B isolates from the YKD region was recovered from a 1-year-old Native Alaskan infant in the Bristol Bay region of the state. In 1995, an isolate that was penicillin-intermediate, TMP-SMXintermediate, and erythromycin-resistant and that was determined (by PFGE analysis) to be highly related to the 6B isolates circulating in the YKD region was recovered from a nonnative infant !2 years of age residing in the Interior region of the state. A year later, a penicillin-resistant (MIC у2 mg/mL) serotype 6B isolate was recovered from a nonnative adult patient in this same region; this serotype, too, was determined by PFGE analysis to be similar to the genetically-related serotype 6B isolates circulating in the western part of Alaska. Further analysis is needed to determine whether the appearance of these 3 isolates in other regions of the state is a result of geographic spread of the serotype 6B genetically related isolates from western Alaska, 1 of which has now acquired penicillin resistance (MIC у2 mg/mL), or of some other phenomenon, such as capsular transformation.
Analysis of penicillin-resistant and multidrug-resistant pneumococcal isolates from several different countries worldwide by a number of genotypic techniques has shown that, in general, common organisms circulating in local areas are derivatives of a relatively small number of clonal genotypes. Previously, Munoz et al. [9] characterized pneumococcal isolates of serotypes 6B, 19A, and 23F by the penicillin-binding protein profile, PspA serotyping, and multilocus enzyme electrophoresis. Included in this analysis were 12 serotype 6B isolates, 11 of which were penicillin nonsusceptible and recovered from patients from the YKD region. The remaining isolate, which was penicillin susceptible, was recovered from a patient from the Southcentral region of the state. All 12 isolates shared a common penicillinbinding protein family profile (e), were of a distinct multilocus enzyme type (E), and a single PspA type (serotype 16). The 11 penicillin-nonsusceptible isolates were available for PFGE typing in our study. Eight of these 11 isolates were found to be genetically indistinguishable after restriction enzyme digestion with all 3 enzymes; the remaining 3 were determined to be highly related. Our study also included 22 penicillin-susceptible serotype 6B isolates recovered from patients from the Southcentral, YKD, and Interior regions of the state; 4 of these isolates were found to be genetically related to the penicillinnonsusceptible isolates. Taken together, the results of both studies support what Sa Figueiredo et al. [24] previously suggested, namely, that the evolution of penicillin resistance may follow a stepwise progression of low to intermediate to high levels and that the genetic background of highly resistant strains should be present among intermediate-level isolates, which would represent an evolutionary stage in the process that must have begun with an ancestral susceptible cell of the same or highly similar genetic background. Therefore, it is possible that the low-level penicillin-resistant (MIC 0.125-1.0 mg/mL) isolates may represent putative ancestral intermediates to the fully penicillinresistant isolate recently recovered from the Interior region.
Particular multidrug-resistant clones have become common in certain areas, and some of these have spread between different countries and continents, reflecting the social mobility of human populations [11] [12] 26] . When we compared a representative of the genetically related serotype 6B isolates from Alaska with well-characterized and described serotype 6B clones from Spain and South Africa by PFGE, their patterns differed markedly (13-band difference with each enzyme). Because the majority of penicillin-nonsusceptible and multidrugresistant serotype 6B pneumococcal isolates in Alaska were recovered from a remote region of the state several years before other clones were identified, it is most likely that they represent the independent emergence of a distinct clone from this region, rather than importation and geographic spread of a previously described 6B clone (Spain 6B-2 or South Africa 6B-8). Because of the increase in the number of reports describing new pneumococcal clones, a network was established in 1997 and includes representatives of national reference centers and individuals who have identified pneumococcal clones, to serve as a repository for the interchange of strains and information on clones between laboratories [27] . We submit, on the basis of data presented here, that the Alaskan 6B clone meets the criteria for inclusion in this pneumococcal molecular epidemiology network.
